A conserved region of unknown function participates in the recognition of E2F family members by the adenovirus E4 ORF 6/7 protein

Virology

Volumn 220, Issue 1, 1996, Pages 78-90

  Jost, Christine A ^b   Ginsberg, Doron ^b   Kaelin Jr , William G ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE;

VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSACTIVATION;

ADENOVIRUS E4 PROTEINS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CARRIER PROTEINS; CELL CYCLE PROTEINS; CONSERVED SEQUENCE; DNA, VIRAL; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0029953586     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0288     Document Type: Article

References (82)

1. Arroyo, M., and Raychaudhuri, P. (1992). Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein. Nucleic Acids Res. 20, 5947-5954.
2. Bandara, L., Lam, E., Sorensen, T., Zamanian, M., Girling, R., and La Thangue, N. (1994). DP-1: A cell cycle-regulated and phosphorylated component of transcription factor DRTF/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J. 13, 3104-3114.
3. Bandara, L. R., Buck, V. M., Zamaian, M., Johnston, L. H., and La Thangue, N. B. (1993). Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12, 4317-4324.
4. Bandara, L. R., and La Thangue, N. B. (1991). Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351, 494-497.
5. Beijersbergen, R. L., Kerkhoven, R. M., Zhu, L., Carlee, L., Voorhoeve, P. M., and Bernards, R. (1994). E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8, 2680-2690.
6. Blake, M., and Azizkhan, J. C. (1989). Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9, 4994-5002.
7. Bookstein, R., Shew, J., Chen, P., Scully, P., and Lee, W. (1990). Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247, 712-715.
8. Cao, L., Faha, B., Dembski, M., Tsai, L.-H., Harlow, E., and Dyson, N. (1992). Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355, 176-179.
9. Chen, C., and Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
10. Cobrinik, D., Whyte, P., Peeper, D. S., Jacks, T., and Weinberg, R. A. (1993). Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7, 2392-2404.
11. Cress, D. W., Johnson, D. G., and R., N. J. (1993). A genetic analysis of the E2F-1 gene distinguishes regulation by RB, p107, and adenovirus E4. Mol. Cell. Biol. 13, 6314-6325.
12. Cress, W., and Nevins, J. (1994). Interacting domains of E2F1, DP1, and the adenovirus E4 protein. J. Virol. 68, 4212-4219.
13. Dalton, S. (1992). Cell cycle regulation of the human cdc2 gene. EMBO J. 11, 1797-1804.
14. Devoto, S. H., Mudryj, M., Pines, J., Hunter, T., and Nevins, J. R. (1992). A cyclin A protein kinase complex possesses sequence specific DNA binding activity; p33cdk2 is a component of the E2F-Cyclin A complex. Cell 68, 167-176.
15. Dynlacht, B. D., Brook, A., Dembski, M., Yenush, L., and Dyson, N. (1994). DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. Proc. Natl. Acad. Sci. USA 91, 6359-6363.
16. Ewen, M. E., Faha, B., Harlow, E., and Livingston, D. M. (1992). Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 255, 85-87.
17. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., and Livingston, D. M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497.
18. Fagan, R., Flint, K. J., and Jones, N. (1994). Phosphorylation of E2F1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19kD protein. Cell 78, 799-811.
19. Faha, B., Ewen, M., Tsai, L., Livingston, D. M., and Harlow, E. (1992). Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 255, 87-90.
20. Farnham, P. J., Slansky, J. E., and Kollmar, R. (1993). The role of E2F in the mammalian cell cycle. Biochemica et Biophysica Acta 1155, 125-131.
21. Flemington, E. K., Speck, S. H., and Kaelin, W. G. (1993). E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90, 6914-6918.
22. Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z-X., Xu, G., Wydner, K. L., DeCaprio, J. A., Lawrence, J. B., and Livingston, D. M. (1994). E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8, 2665-2679.
23. Goodrich, D. W., Wang, N. P., Qian, Y.-W., Lee, E. Y.-H. P., and Lee, W.-H. (1991). The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67, 293-302.
24. Hagemeier, C., Cook, A., and Kouzarides, T. (1993). The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21, 4998-5004.
25. Hamel, P. A., Gill, R. M., Phillips, R. A., and Gallie, B. L. (1992). Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12, 3431-3438.
26. Hardy, S., Engel, D., and Shenk, T. (1989). An adenovirus early region 4 gene product is required for induction of infection-specific form of cellular E2F activity. Genes Dev. 3, 1062-1074.
27. Hardy, S., and Shenk, T. (1989). E2F from adenovirus-infected cells binds cooperatively to DNA containing two properly oriented and spaced recognition sites. Mol. Cell Biol. 9, 4495-4506.
28. Helin, K., and Harlow, E. (1994). Heterodimerization of the transcription factors E2F1 and DP1 is required for binding to the adenovirus E4 (ORF 6/7) protein. J. Virol. 68, 5027-5035.
29. Helin, K., Harlow, E., and Fattaey, A. (1993). Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma gene. Mol. Cell. Biol. 13, 6501-6508.
30. Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E., and Fattaey, A. (1992). A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 337-350.
31. Helin, K., Wu, C.-L., Fattaey, A. R., Lees, J. A., Dynlacht, B. D., Ngwu, C., and Harlow, E. (1993). Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7, 1850-1861.
32. Hiebert, S. W (1993). Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-Mediated growth suppression. Mol. Cell. Biol. 13, 3384-3391.
33. Hiebert, S. W., Blake, M., Azizkhan, J., and Nevins, J. R. (1991). Role of E2F transcription factor in E1A-mediated trans activation of cellular genes. J. Virol. 65, 3547-3552.
34. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M., and Nevins, J. R. (1992). The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6, 177-185.
35. Hijmans, E. M., Voorhoeve, P. M., Beijersbergen, R. L., Van T Veer, L. J., and Bernards, R. (1995). E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15, 3082-3089.
36. Horowitz, J.M., Park, S., Bogenmann, E., Cheng, J., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P., and Weinberg, R. A. (1990). Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87, 2775-2779.
37. Horowitz, J. M., Yandell, D. W., Park, S., Canning, S., Whyte, P., Buchkovich, K., Harlow, E., Weinberg, R. A., and Dryja, T. P. (1989). Point mutational inactivation of the retinoblastoma antioncogene. Science 243, 937-940.
38. Hsiao, K.-M., McMahon, S. L., and Farnham, P. (1994). Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8, 1526-1537.
39. Huang, M. M., and Hearing, P. (1989). The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex. Genes Dev. 3, 1699-1710.
40. Huber, H. E., Edwards, G., Goodhart, P. J., Patrick, D. R., Huang, P. S., Ivey-Hoyle, M., Barnett, S. F., Oliff, A., and Heimbrook, D. C. (1993). Transcription factor E2F binds DNA as a heterodimer. Proc. Natl. Acad. Sci. USA 90, 35-25.
41. Ivey-Hoyle, M., Conroy, R., Huber, H. E., Goodhart, P. J., Oliff, A., and Heimbrook, D. C. (1993). Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13, 7802-7812.
42. Johnson, D. G., Ohtani, K., and Nevins, J. R. (1994). Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8, 1514-1525.
43. Kaelin, W. G., Krek, W., Sellers, W. R., DeCaprio, J. A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T., Li, Y., Farnham, P. J., Blanar, M. A., Livingston, D. M., and Flemington, E. K. (1992). Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351-364.
44. Kaye, F. J., Kratzke, R. A., Gerster, J. L., and Horowitz, J. M. (1990). A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87, 6922-6926.
45. Kovesdi, I., Reichel, R., and Nevins, J. R. (1986a). E1A transcription induction: Enhanced binding of a factor to upstream promoter sequences. Science 231.
46. Kovesdi, I., Reichel, R., and Nevins, J. R. (1986b). Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45, 219-228.
47. Krek, W., Livingston, D. M., and Shirodkar, S. (1993). Binding to DNA and retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262, 1557-1560.
48. La Thangue, N. (1994). DP and E2F proteins: Components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opinion Cell Biol. 6, 443-450.
49. Lam, E. W.-F., and Watson, R. J. (1993). An E2F-binding site mediates cell-cycle regulated repression of mouse B-Myb transcription. EMBO J. 12, 2705-2713.
50. Lees, E., Faha, B., Dulic, V., Reed, S. I., and Harlow, E. (1992). Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6, 1874-1885.
51. Lees, J. A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N., and Helin, K. (1993). The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13, 7813-7825.
52. Marton, M. J, Baim, S. B., Ornelles, D. A., and Shenk, T. (1990). The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA. J. Virol. 64, 2345-2359.
53. Means, A. L., Slansky, J. E., McMahon, S. L., Knuth, M. W., and Farnham, P. J. (1992). The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol. Cell. Biol. 12, 1054-1063.
54. Moberg, K. H., Logan, T. J., and Tyndall, D. J. (1992). Three distinct elements within the murine c-myc promoter are required for transcription. Oncogene 7, 411-421.
55. Mudryj, M., Devoto, S. H., Hiebert, S. W., Hunter, T., Pines, J., and Nevins, J. R. (1991). Cell cycle regulation of the E2F transcription factor involves an interactin with cyclin A. Cell 65, 1243-1253.
56. Mudryj, M., Hiebert, S. W., and Nevins, J. R. (1990). A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9, 2179-2184.
57. Neill, S. D., Hemstrom, C., Virtanen, A., and Nevins, J. (1990). An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F. Proc. Natl. Acad. Sci. USA 87, 2008-2012.
58. Neill, S. D., and Nevins, J. R. (1991). Genetic analysis of the adenovirus E4 6/7 trans activator: Interaction with E2F and induction of a stable DNA-protein complex are critical for activity. J. Virol. 65, 5364-5373.
59. Neuman, E., Flemington, E. K., Sellers, W. R., and Kaelin, W. G. (1994). Transcription of the E2F1 gene is rendered cell-cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14, 6607-6615.
60. Nevins, J. R. (1992). E2F: A link between the Rb tumor supressor protein and viral oncoproteins. Science 258, 424-429.
61. O'Connor, R. J., and Hearing, P. (1991). The C-terminal 70 amino acids of the adenovirus E4-ORF 6/7 protein are essential and sufficient for E2F complex formation. Nucleic Acids Res. 19, 6579-6586.
62. O'Connor, R. J., and Hearing, P. (1994). Mutually exclusive interactions of the adenovirus E4 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1. J. Virol. 68, 6848-6862.
63. Obert, S., O'Connor, R., Schmid, S., and Hearing, P. (1994). The adenovirus E4-6/7 protein transactivates the E2 promotor by inducing dimerization of a heteeromeric E2F complex. Mol. Cell Biol. 14, 1333-1346.
64. Ohtani, K., and Nevins, J. R. (1994). Functional properties of a Drosophila homolog of the E2F1 gene. Mol. Cell. Biol. 14, 1603-1612.
65. Pagano, M., Draetta, G., and Jansen-Durr, P. (1992). Association of cdk2 kinase with the transcription factor E2F during SD phase. 255, 1144-1147.
66. Pearson, B. E., Nasheuer, H. P., and Wang, T. S. F. (1991). Human DNA polymerase a gene, sequences controlling expression in cycling and serum-stimulated cells. Mol. Cell. Biol. 11, 2081-2095.
67. Qian, Y., Luckey, C., Horton, L., Esser, M., and Templeton, D. J. (1992). Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol. Cell. Biol. 12, 5363-5372.
68. Qin, X.-Q., Livingston, D. M., Ewen, M., Sellers, W. R., Arany, Z., and Kaelin, W. G. (1995). The transcription factor E2F1 is a downstream target of RB action. Mol. Biol. Cell. 15, 742-755.
69. Qin, X.-Q., Chittenden, T., Livingston, D. M., and Kaelin, W. G. (1992). Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953-964.
70. Raychaudhuri, P., Bagchi, S., Neill, S., and Nevins, J. (1990). Activation of the E2F transcription factor in adenovirus-infected cells involves E1A-dependent stimulation of DNA-binding activity and induction of coorporative binding mediated by an E4 gene product. J. Virol. 64, 2702-2710.
71. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R. A. (1995). E2F-4 and E2F-5, two novel members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92, 2403-2407.
72. Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. (1991). The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88, 5523-5527.
73. Schwarz, J. K., Devoto, S. H., Smith, E. J., Chellappan, S. P., Jakoi, L., and Nevins, J. R. (1993). Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12, 1013-1020.
74. Shan, B., Zhu, X., Chen, P.-L., Durfee, T., Yang, Y., Sharp, D., and Lee, W.-H. (1992). Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: Identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12, 5620-5631.
75. Shew, J., Chen, P., Bookstein, R., Lee, E. Y., and Lee, W. (1990). Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen. Cell Growth Diff. 1, 17-25.
76. Shirodkar, S., Ewen, M., DeCaprio, J. A., Morgan, J., Livingston, D. M., and Chittenden, T. (1992). The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68, 157-166.
77. Smith, E. J., and Nevins, J. R. (1995). The Rb related p107 protein can suppress E2F Function Independently of binding to Cyclin A/cdk2. Mol. Cell Biol. 15, 338-344.
78. Thalmeier, K., Synovzik, H., Mertz, R., Winnacker, E.-L., and Lipp, M. (1989). Nuclear factor E2F mediates basic transcription and transactivation by E1A of the human MYC promoter. Genes Dev. 3, 527-536.
79. Weintraub, S. J., Prater, C. A., and Dean, D. C. (1992). Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259-261.
80. Yamamoto, M., Yoshida, M., Ono, K., Fujita, T., Ohtani-Fujita, N., Sakai, T., and Nikaido, T. (1994). Effect of Tumor Suppressors on Cell Cycle-Regulatory Genes: RB Suppresses p34cdc2 Expression and Normal p53 Suppresses Cyclin A Expression. Exp. Cell. Res. 210, 94-101.
81. Zamanian, M., and La Thangue, N. B. (1992). Adenovirus E1A Prevents the Retinoblastoma Gene Product from Repressing the Activity of a Cellular Transcription Factor. EMBO J. 11, 2603-2610.
82. Zhu, L., van der Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., and Harlow, E. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111-1125.